Search Back New search Go to resultsDiseaseMain groupHematological Diseases, Non-MalignantProtocol groupAnemias, CytopeniasDiseaseNeutropeniaSubgroupICD10D70.-MeSHAgranulocytosisNeutropeniaSequenceChemotherapyChemo-substanceChemo-substanceChemo-substanceChemo-substanceNo. Substances RadiotherapySupportive therapySupportive substanceFilgrastimLipegfilgrastimPegfilgrastimSupportive substanceFilgrastimLipegfilgrastimPegfilgrastimSupportive substanceFilgrastimLipegfilgrastimPegfilgrastimSupportive substanceFilgrastimLipegfilgrastimPegfilgrastimNo. Substances1Protocol classificationTherapy classificationcurrent standardIntensityStandard doseTherapy indicationTherapy phaseTherapy intentionsupportiveRisksBone PainCapillary Leak SyndromeDyspneaHeadacheHypokalemiaInfectionsPainPneumoniaRenal FailureThrombocytopenia below 50 000/µl only studiesPublicationAuthorAapro MCrawford JDiseaseSekundäre Neutropenie-ProphylaxeOriginCancer Center, Clinique de Genolier, Vaud, SwitzerlandDuke University Medical Center and Durham Veterans Affairs Medical Center, Durham, USAProtocols in Revision 3 protocols foundProtocols under revision.Filgrastim 5, Neutropenia (PID1554 V1.0)Lipegfilgrastim 6, Neutropenia (PID1539 V1.0)Pegfilgrastim 6, Neutropenia (PID1538 V1.0)
